Home    Back

Synergy-1    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis2

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,269 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02865707
(ClinicalTrials.gov)		August 201612/7/2016Ulcerative Colitis Relapse Prevention by PrebioticsPrevention of Ulcerative Colitis by Prebiotics: Efficacy and Protective MechanismsUlcerative ColitisDietary Supplement: Synergy-1;Dietary Supplement: MaltodextrinUniversity of AlbertaUniversity of British ColumbiaRecruiting18 Years75 YearsAll100N/ACanada
2NCT02093767
(ClinicalTrials.gov)		August 200719/3/2014Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative ColitisOpen-Label Trial of a Prebiotic Preparation Containing Inulin and Oligofructose (Synergy-1) for the Treatment of Mild to Moderate Acute Ulcerative ColitisUlcerative ColitisDietary Supplement: Synergy1University of AlbertaCanadian Institutes of Health Research (CIHR);Crohn's and Colitis Canada;Beneo GmbHCompleted18 Years65 YearsAll24N/ACanada